Carbon dots are quasi-zero-dimensional carbon nanomaterials, typically smaller than ten nanometers, that have attracted intense interest for their photoluminescence, ease of surface functionalization, and low toxicity. In recent years, biomass has emerged as a sustainable and cost-effective feedstock for these nanoparticles, offering renewable supply chains and greener synthesis routes compared with synthetic molecular precursors. Yet crude biomass presents a fundamental problem. Composed of mixtures of polysaccharides, proteins, organic acids, and other constituents, it triggers competing reactions during carbonization, yielding structurally heterogeneous products with batch-to-batch variability. That heterogeneity translates into uneven distributions of anchoring sites on the resulting dots, which in turn causes uncontrolled aggregation of metal nanoparticles and poor signal reproducibility in the final SERS substrates.

The research team, led by Chengwei Hu and corresponding author Hong Bi of Anhui University, sidestepped this problem by starting from a structurally well-defined biomacromolecule rather than crude plant matter. Polygonatum cyrtonema Hua polysaccharide, abbreviated PcH, was extracted from dried rhizomes using hot-water extraction followed by ethanol precipitation, deproteinization, decolorization, dialysis, and lyophilization. Mass spectrometric analysis revealed a glucan-type backbone with a regular 162-dalton interval between dominant peaks, corresponding to hexose units, while chromatographic analysis of the acid hydrolysate confirmed glucose as the predominant monosaccharide. The polymer showed a moderately polydisperse population of oligomers with degrees of polymerization of roughly eight to sixteen, and thermogravimetric analysis demonstrated thermal stability up to about 300 degrees Celsius, a property that proved essential for the hydrothermal steps to follow.

The key innovation lies in what the researchers did next. Rather than carbonizing the polysaccharide directly, they first oxidized it selectively with sodium periodate under acidic conditions, converting vicinal diols into dialdehyde functionalities. Quantification using the Schiff reagent method showed the relative oxidation degree jumping from 1.26 percent in the pristine polysaccharide to 96.62 percent in the oxidized product, a near-complete conversion. The dialdehyde intermediate was then condensed with L-lysine, an amino acid whose primary amines react with the aldehyde groups to form imine linkages, the hallmark of Schiff-base chemistry. Nuclear magnetic resonance spectroscopy confirmed the formation of these -C=N- bonds with a characteristic resonance near 8.3 parts per million, while infrared spectroscopy showed the carbonyl band near 1720 wavenumbers weakening as a new band emerged around 1650 to 1680 wavenumbers, consistent with C=N stretching.

These imine motifs are far more than decorative. Nitrogen atoms in imine groups carry lone pairs of electrons embedded in an extended pi-conjugated system, making them excellent coordination sites for metal ions. Crucially, the team demonstrated that these functionalities survive the subsequent hydrothermal carbonization, in which the Schiff-base-functionalized precursor was heated at 160 degrees Celsius for six hours in a sealed autoclave. The resulting carbon dots, termed PcH-CDs, emerged as uniformly dispersed quasi-spherical particles averaging about 2.5 nanometers in diameter, with lattice fringes of roughly 0.20 nanometers corresponding to the (100) plane of graphitic carbon. X-ray diffraction showed the amorphous polysaccharide peak at 22 degrees shifting to 26 degrees after carbonization, indicative of a graphite-like sp2-conjugated framework, while Raman spectroscopy revealed the ratio of disorder to graphitic band intensities dropping from 1.59 to 0.75, signaling increased structural ordering.

With the imine sites preserved on the carbon dot surfaces, the researchers introduced silver through a silver-ammonia complex reduction. The surface-exposed -C=N- groups selectively coordinated silver ions, guiding uniform in-situ nucleation and suppressing the random aggregation that plagues conventional syntheses. Transmission electron microscopy showed the hybrid nanoparticles growing to an average of 13.23 nanometers, with silver nanocrystals of roughly 7 to 10 nanometers estimated from X-ray diffraction line broadening. X-ray photoelectron spectroscopy delivered perhaps the most telling evidence: the silver 3d binding energies in the hybrid were blue-shifted by 0.80 electron volts relative to silver nitrate, a shift attributable to strong coordination between silver and the imine nitrogen, which acts as a stronger electron donor than oxygen and withdraws electron density from the metal center. A control sample prepared from unmodified polysaccharide, lacking these nitrogen sites, showed only minor shifts characteristic of weaker silver-oxygen coordination and exhibited markedly weaker silver diffraction peaks.

The practical payoff came in SERS testing. When Rhodamine B was applied to the PcH-CDs-Ag substrate, the characteristic Raman peak at 1650 wavenumbers remained clearly visible down to a concentration of 1 x 10^-10 molar, with a linear calibration spanning ten^-10 to ten^-6 molar and a correlation coefficient of 0.99. The calculated enhancement factor reached 4.21 x 10^6, roughly three orders of magnitude higher than that of metal-free nitrogen-doped graphene quantum dots for the same analyte. Signal reproducibility, measured across twenty randomly selected points on a single substrate, yielded a relative standard deviation of 11.7 percent, an acceptable figure for practical analytical work. The substrate also proved durable: after six weeks of ambient storage, SERS intensities retained approximately 70 percent of their initial values, with the carbon dot matrix apparently protecting the silver nanoparticles from oxidation. Methylene blue served as a second probe molecule, detectable down to 1 x 10^-8 molar, confirming the platform’s versatility beyond a single analyte.

To understand why the nitrogen-coordinated system outperforms its oxygen-coordinated counterpart, the team turned to density functional theory. Optimized geometries showed an Ag-N bond length of 1.97 angstroms, significantly shorter than the 2.14-angstrom Ag-O bond, indicating a stronger and more localized interaction. Natural bond orbital analysis quantified the difference dramatically: the donor-acceptor interaction from the imine pi bond to the silver acceptor orbital exhibited a second-order stabilization energy of 71.6 kilocalories per mole with an orbital occupation number of 0.39639, whereas the corresponding oxygen-to-silver interaction registered below 3 kilocalories per mole with an occupation number of just 0.01314. The Ag-N system also displayed a substantially narrowed band gap of 1.63 electron volts compared with 3.46 electron volts for Ag-O, conditions that favor excited-state charge transfer across the molecule-metal interface and amplify the chemical enhancement contribution to the SERS signal.

Beyond the immediate analytical performance, the study carries a broader message about how natural polysaccharides can be used in materials design. The authors argue that glycans should be viewed not merely as sustainable carbon sources but as chemically tunable platforms whose repeating-unit backbones and abundant hydroxyl groups allow precise, site-specific molecular modification. By combining regioselective oxidation, Schiff-base condensation, hydrothermal carbonization, and coordination-directed metal deposition, the researchers demonstrated a molecular route to controllable carbon-metal hybrid nanoparticles in which interfacial chemistry, rather than chance, dictates performance. The aqueous processability of the hybrid, along with its uniform silver loading, suggests suitability for coating onto flexible substrates, opening possibilities for lightweight, portable SERS devices for environmental monitoring, food safety testing, and trace detection of organic pollutants. Extending this strategy to other polysaccharide systems, the team suggests, could open new avenues for sustainable materials in advanced sensing applications, turning an ancient medicinal plant into a blueprint for next-generation nanosensors.

Subject of Research: Schiff-base-functionalized carbon dots derived from Polygonatum cyrtonema Hua polysaccharide decorated with silver nanoparticles for surface-enhanced Raman scattering detection of trace organic pollutants

Article Title: Silver decorated Schiff base functionalized carbon dots derived from Polygonatum cyrtonema Hua polysaccharide for surface enhanced Raman scattering

Article References: Hu, C., Zhu, H., Cui, J., Xue, J., Liu, J., Liu, C., & Bi, H. (2026). Silver decorated Schiff base functionalized carbon dots derived from Polygonatum cyrtonema Hua polysaccharide for surface enhanced Raman scattering. Discover Green Chemistry, 1(1), Article 23. https://doi.org/10.1007/s44509-026-00024-0

Image Credits: AI Generated

DOI: 10.1007/s44509-026-00024-0

Keywords: carbon dots, SERS, Polygonatum cyrtonema Hua, polysaccharide, Schiff base, silver nanoparticles, surface-enhanced Raman scattering, biomass, green chemistry, Rhodamine B, density functional theory, nanosensors

The scale of the underlying problem is enormous. According to figures cited in the study, roughly 828 million people worldwide were living with diabetes in 2022, with type 2 diabetes accounting for 96 percent of cases. MASLD, a spectrum of liver disease ranging from simple fatty liver to inflammation, fibrosis, cirrhosis, and even liver cancer, now affects an estimated 39 percent of the global population and is increasingly diagnosed in younger people. Critically, the two diseases are frequent companions: epidemiological studies suggest that up to 65 percent of patients with type 2 diabetes also have MASLD. They share a common pathological root in disordered glucose and lipid metabolism, and each worsens the other in a self-reinforcing cycle that accelerates cardiovascular and liver complications.

Current treatment options for this comorbidity remain limited. Weight loss through lifestyle change is the foundation of therapy for both conditions, but its effects are often insufficient on their own. Hypoglycemic drugs, newer injectable agents, and bariatric surgery show promise, yet safe and effective interventions designed specifically for diabetes-associated MASLD are still lacking. This therapeutic gap motivated the research team to look toward edible-medicinal plants, a traditional source of bioactive compounds, and in particular toward Polygonatum cyrtonema Hua, a tonic herb long used in Chinese medicine for its purported benefits in diabetes and hyperlipidemia. While polysaccharides are recognized as the herb’s major active constituents, their specific effects and mechanisms in diabetes-related liver disease had remained unclear.

The team isolated and purified the polysaccharide fraction they named PCP III from dried rhizomes using ethanol pretreatment, hot-water extraction, and stepwise ethanol precipitation. Characterization revealed a molecule with distinctive physical properties: a total sugar content of 90.76 percent, a modest protein content of about 6 percent, and a remarkably low average molecular weight of approximately 2.4 kilodaltons. Chromatographic analysis of its monosaccharide building blocks showed that fructose and glucose dominate the composition, accounting for roughly 65 and 33 percent respectively, with smaller amounts of galactose, glucosamine, arabinose, and galactosamine. Infrared spectroscopy confirmed the classic polysaccharide fingerprint of hydroxyl, carbon-hydrogen, and glycosidic bond vibrations. The researchers suggest that the compound’s low molecular weight may facilitate absorption or interaction with gut epithelial cells compared with larger polysaccharides, potentially contributing to its biological activity.

To test the compound’s effects, the researchers used a well-established mouse model that mimics the progressive nature of human disease. Young male C57BL/6J mice were fed a diet deriving 60 percent of calories from fat for eight weeks and then injected with streptozotocin, a chemical that damages insulin-producing cells, to induce type 2 diabetes. Only mice with fasting blood glucose at or above 11.1 millimoles per liter and histologically confirmed fatty liver were included. The diabetic mice were then divided into groups receiving either no treatment, the diabetes drug metformin, the cholesterol-lowering drug atorvastatin, or PCP III at low or high doses of 500 or 1000 milligrams per kilogram of body weight daily for eight weeks.

The results were striking. Untreated diabetic mice gained weight steadily, developed enlarged livers and expanded fat stores, showed persistent hyperglycemia, cleared glucose poorly in tolerance tests, and displayed elevated total cholesterol, triglycerides, and LDL cholesterol along with elevated liver enzymes indicating hepatocellular damage. PCP III treatment attenuated weight gain without reducing food or water intake, lowered fasting blood glucose, improved glucose tolerance, partially corrected the lipid profile with a particularly clear reduction in LDL cholesterol at the high dose, and significantly decreased the liver injury markers gamma-glutamyl transferase, alanine aminotransferase, and aspartate aminotransferase. The compound also lowered serum levels of glycated serum protein and insulin, and reduced the abnormal elevation of both leptin and its soluble receptor, pointing to a partial restoration of leptin-related metabolic regulation.

Direct examination of liver tissue reinforced the biochemical findings. Livers from untreated model mice were visibly enlarged, pale, and greasy, and microscopy revealed swollen hepatocytes crowded with lipid vacuoles and disordered hepatic cords. Oil Red O staining confirmed abundant fat droplet deposition, and ultrasound imaging showed the characteristic brightened liver echo texture, blurred vessel walls, and deep echo attenuation of hepatic steatosis. After PCP III treatment, particularly at the high dose, liver appearance normalized, histological fat accumulation fell, and ultrasonographic abnormalities improved. The compound also rebalanced hepatic oxidative stress, restoring the activities of the antioxidant enzymes superoxide dismutase and glutathione peroxidase and reducing the lipid peroxidation product malondialdehyde, all of which had been deranged by the disease process.

The mechanistic core of the study came from liver transcriptome sequencing combined with validation experiments. Untreated model mice showed 237 differentially expressed genes relative to healthy controls, whereas PCP III intervention altered 1599 genes, revealing an extensive remodeling of the hepatic transcriptional network. Forty-two genes changed in common across comparisons, and pathway analysis pointed squarely at the peroxisome proliferator-activated receptor, or PPAR, signaling pathway, alongside oxidative phosphorylation and steroid biosynthesis. Quantitative PCR and Western blotting confirmed that the compound increased expression of PPAR alpha and its downstream targets involved in fatty acid transport and oxidation, including the transporter Slc27a1 and the bile acid synthesis enzyme CYP7A1, while suppressing PPAR gamma, the lipid droplet protein PLIN2, and the fatty acid binding protein FABP2, which were abnormally elevated in disease. In essence, PCP III appeared to shift the liver away from fat storage and toward fat burning and cholesterol-to-bile-acid conversion.

The gut microbiota emerged as a second, complementary target. Sequencing of bacterial 16S rRNA genes from intestinal contents showed that diseased mice had altered community structure and depleted populations of several beneficial taxa, including members of Muribaculaceae, Clostridia UCG-014, and Dubosiella, while an opportunistic group within Erysipelotrichaceae expanded. High-dose PCP III partially reversed these shifts, restoring the beneficial genera toward the profile seen in healthy mice. Correlation analysis revealed that Clostridia UCG-014 abundance tracked positively with hepatic antioxidant enzyme levels and negatively with serum insulin, leptin, and LDL cholesterol, while Dubosiella was inversely associated with liver injury markers. Gas chromatography-mass spectrometry of cecal contents showed that PCP III also reshaped short-chain fatty acids, raising isohexanoic acid and lowering valeric, isobutyric, isovaleric, and acetic acids. Because short-chain fatty acids absorbed through the portal vein can activate hepatic PPAR alpha and strengthen the gut barrier, the authors propose that microbial remodeling and PPAR modulation form a linked, multi-target network underlying the compound’s benefit.

The authors are careful to note the study’s limitations. No pharmacological antagonist or genetic knockout was used to prove that PPAR signaling is causally required for the effects, so the mechanism remains associative; microbiota and metabolite analyses were limited to the high-dose group; only male mice were studied; the HFD and streptozotocin model does not fully recapitulate human disease; and the fine structural features of the polysaccharide, such as its glycosidic linkages and branching, remain unresolved. Even so, the convergence of phenotypic, histological, transcriptomic, protein-level, microbiological, and metabolomic evidence makes PCP III a compelling candidate for development as a functional food ingredient or nutritional supplement aimed at the metabolic comorbidity of type 2 diabetes and MASLD. Future work validating the findings in clinical cohorts and pinpointing the specific microbial metabolites involved will determine whether a sugar molecule from a humble medicinal rhizome can one day help break the vicious cycle that links two of the world’s fastest-growing chronic diseases.

Subject of Research: A purified polysaccharide from Polygonatum cyrtonema Hua that alleviates type 2 diabetes-associated fatty liver disease by regulating the PPAR pathway and gut microbiota.

Article Title: Polysaccharide III from Polygonatum cyrtonema Hua alleviates diabetes-associated MASLD via PPAR pathway-mediated regulation of lipid metabolism and gut microbiota modulation

Article References: Chen, S., Ren, Z., Guo, Z., Mei, X., Chen, X., Tong, Y., Fan, X., & Dai, G. (2026). Polysaccharide III from Polygonatum cyrtonema Hua alleviates diabetes-associated MASLD via PPAR pathway-mediated regulation of lipid metabolism and gut microbiota modulation. Journal of Agriculture and Food Research, 31, Article 103254. https://doi.org/10.1016/j.jafr.2026.103254

Image Credits: AI Generated

DOI: 10.1016/j.jafr.2026.103254

Keywords: Polygonatum cyrtonema, polysaccharide, MASLD, type 2 diabetes, PPAR signaling, gut microbiota, hepatic steatosis, short-chain fatty acids, insulin resistance, lipid metabolism, functional foods, mouse model